Nuclear weapons

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Harald Brune

Originaire de Münich en Allemagne, né en 1961, Harald Brune obtient son diplôme en physique de l'Université Ludwig Maximilians en 1989. Après une thèse en chimie physique à l'Institut Fritz-Haber de la Société Max-Planck à Berlin il obtient son titre de docteur ès sciences en 1992. Dès cela, il rejoint le groupe du Prof. K. Kern à l'Institut de physique expérimentale à l'EPFL. En 1995 il est chercheur invité à Copenhague travaillant en modélisation chez le Prof. J. Nørskov. De retour à l'EPFL, il se voit décerné le prix Latsis EPFL 1996 pour ses études par microscopie à effet tunnel de processus atomiques déterminants la croissance cristalline de couches minces. En 1998 il obtient son habilitation (venia legendi) en Physique et est nommé Maître d'enseignement et de recherche (MER) en nanophysique à l'EPFL. La même année il recoit une offre de Professeur Ordinaire (C4) de l'Université Philipps de Marburg. Début 1999 il réfuse cette offre et accepte un poste de Professeur Extraordinaire à l'EPFL et s'installe au sein de l'Institut de la Physique des Nanostructures. Il est nommé Professeur Ordinaire en 2005. Sa recherche porte sur les propriétés physiques (en particulier le magnétisme et la structure électronique) de nouvelles formes de la matière condensée comme des nanostructures et des couches ultra-minces. Il s'intéresse également à la catalyse hétérogène sur des systèmes inspirés dans leur composition et taille par celle des sites actives dans les enzymes en biologie. Il enseigne la Physique Générale pour ingénieurs, la Physique des matériaux solides pour physiciens, les méthodes expérimentales pour physiciens, ainsi que la Physique des surfaces, interfaces et nanostrcutures à l'école doctorale.

Hatice Altug

2020-current Full Professor at the Institute of Bioengineering, EPFL, Switzerland2013-2020 Associate Professor (with tenure) at the Institute of Bioengineering, EPFL, Switzerland 2013 Associate Professor (with tenure) at Electrical and Computer Engineering Department of Boston University, USA 2007-2013 Assistant Professor (tenure-track) at Electrical and Computer Engineering Department of Boston University, USA 2007 Post-doctoral Fellow at Center for Engineering in Medicine of Harvard Medical School, USA 2000-2007 PhD. in Applied Physics at Stanford University, USA 1996-2000 B.S. in Physics at Bilkent University, Turkey

Christoph Bostedt

Denis Duboule

Denis Duboule is born in 1955 and is both swiss and french national. He studied biology at the university of Geneva, where he obtained a PhD in mammalian embryology in 1984. He then spent 10 years abroad, first as a group leader in the medical faculty in Strasbourg (France), then at the European Laboratory for Molecular Biology (EMBL) in Germany. In 1993, he was appointed full professor at the university of Geneva, where he chairs the department of Genetics and Evolution ever since 1997. In 2001, he chaired the national center of research Frontiers in Genetics and in 2012 the division III of the SNSF. In 2006, he was appointed full professor at the federal institute of technology (EPFL) in Lausanne, where he leads the laboratory of Developmental Genomics (UpDUB). His research activities are in the fields of embryology, genetics and developmental genomics of mammals, in an evolutionnary context. In particular, his laboratory has been closely associated with the structural and functional studies of mammalian Hox genes, by using mouse molecular genetic approaches. Duboule is also active in the communication of science, is member of the Academia Europea as well as of several academies in Switzerland, France and the Netherland. He is a foreign member of the Royal Society (UK) and of the National Academy of Sciences USA. He has received various scientific prizes and awards, amongst which the Marcel Benoist Prize, the Louis-Jeantet prize for medicine in 1998 or the international INSERM prize in 2010 (see also https://en.wikipedia.org/wiki/Denis_Duboule).

Johan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways. Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards. Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.

Marcel Drabbels

Dr. Marcel Drabbels studied experimental physics at the University of Nijmegen (the Netherlands) and in 1993 obtained his Ph.D. at that same university. He then moved to the University of California at Santa Barbara where he studied the dynamics of highly vibrationally excited molecules and developed a new detection technique to investigate the photodissociation of molecules. When he returned to the Netherlands in 1996 he joined the FOM Institute for Atomic and Molecular Physics in Amsterdam where he worked on the development of new types of infrared imaging and streak cameras. In 1997 Dr. Drabbels was awarded a fellowship of the Royal Dutch Academy of Sciences and he moved to the Free University of Amsterdam where he studied the collision dynamics of molecules and initiated photodissociation experiments using ultrafast lasers. In October 1998 he was appointed as senior scientist at the EPFL where he studies the spectroscopy and dynamics of nanoscale systems. In March 2021 he was promoted to titular professor.

Ulrich Lorenz